Jones Cecilia — SEC Form 4 filings
SEC reporting owner CIK 1840056. 10 Form 4 filings on record with FilingPulse; latest filed 2026-06-23.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-01-24 to 2026-06-23. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 13 legs across 9 filings — 23,914 shares, $796,402 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 35.
- Largest priced transaction: sale of 3,651 shares @ $36.77 ($134,247) in AGIOS PHARMACEUTICALS, INC., filed 2025-09-30.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. (AGIO) | Chief Financial Officer | 10 | — | 13 legs · 23,914 sh · $796,402 | 35 |
Form 4 filings — Jones Cecilia
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-23 | 4 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Option exercise (M): 3,000 (derivative) @ $0 · Grant/award (A): 3,000 (derivative) @ $0 | EDGAR |
| 2026-04-06 | 4 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Option exercise (M): 8,500 @ $0 · Sale (S): 3,141 @ $34.71 · Option exercise (M): 8,500 (derivative) @ $0 | EDGAR |
| 2026-03-03 | 4 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Option exercise (M): 2,000 @ $0 · Sale (S): 594 @ $28.96 · Option exercise (M): 5,666 @ $0 · Sale (S): 1,681 @ $28.96 · Option exercise (M): 4,000 @ $0 · Sale (S): 1,187 @ $28.96 · +8 more | EDGAR |
| 2026-01-02 | 4 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Option exercise (M): 6,000 @ $0 · Sale (S): 2,932 @ $27.09 · Option exercise (M): 6,000 (derivative) @ $0 | EDGAR |
| 2025-09-30 | 4 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Option exercise (M): 7,472 @ $0 · Sale (S): 3,651 @ $36.77 · Option exercise (M): 7,472 (derivative) @ $0 | EDGAR |
| 2025-06-26 | 4 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Option exercise (M): 6,000 @ $0 · Sale (S): 1,780 @ $33.54 · Option exercise (M): 6,000 (derivative) @ $0 | EDGAR |
| 2025-03-04 | 4 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Option exercise (M): 2,000 @ $0 · Sale (S): 594 @ $35.54 · Option exercise (M): 5,667 @ $0 · Sale (S): 1,681 @ $35.54 · Grant/award (A): 12,000 (derivative) @ $0 · Grant/award (A): 15,910 (derivative) @ $0 · +3 more | EDGAR |
| 2024-09-30 | 4 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Option exercise (M): 7,473 @ $0 · Sale (S): 2,542 @ $49.03 · Option exercise (M): 7,473 (derivative) @ $0 | EDGAR |
| 2024-03-05 | 4 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Option exercise (M): 2,000 @ $0 · Sale (S): 672 @ $32.57 · Grant/award (A): 17,000 (derivative) @ $0 · Grant/award (A): 60,000 (derivative) @ $0 · Option exercise (M): 2,000 (derivative) @ $0 | EDGAR |
| 2024-01-24 | 4 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Option exercise (M): 5,380 @ $0 · Sale (S): 1,886 @ $21.64 · Option exercise (M): 5,380 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1840056 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →